Lion Point Capital’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $189K | Hold |
17,038
| – | – | 1.29% | 18 |
|
|
2025
Q1 | $239K | Hold |
17,038
| – | – | 1.52% | 18 |
|
|
2024
Q4 | $283K | Hold |
17,038
| – | – | 1.48% | 18 |
|
|
2024
Q3 | $322K | Hold |
17,038
| – | – | 0.72% | 19 |
|
|
2024
Q2 | $247K | Hold |
17,038
| – | – | 0.45% | 18 |
|
|
2024
Q1 | $264K | Hold |
17,038
| – | – | 0.15% | 21 |
|
|
2023
Q4 | $477K | Sell |
17,038
-17,552
| -51% | -$491K | 0.24% | 19 |
|
|
2023
Q3 | $1.65M | Hold |
34,590
| – | – | 0.73% | 8 |
|
|
2023
Q2 | $3.31M | Buy |
34,590
+4,750
| +16% | +$455K | 1.5% | 6 |
|
|
2023
Q1 | $3.38M | Hold |
29,840
| – | – | 1.39% | 10 |
|
|
2022
Q4 | $3.11M | Sell |
29,840
-1,500
| -5% | -$156K | 0.44% | 15 |
|
|
2022
Q3 | $3.23M | Buy |
31,340
+7,250
| +30% | +$747K | 0.71% | 20 |
|
|
2022
Q2 | $2.66M | Hold |
24,090
| – | – | 0.3% | 25 |
|
|
2022
Q1 | $3.43M | Hold |
24,090
| – | – | 0.8% | 20 |
|
|
2021
Q4 | $4.01M | Hold |
24,090
| – | – | 1.08% | 16 |
|
|
2021
Q3 | $3.35M | Buy |
+24,090
| New | +$3.35M | 0.63% | 23 |
|